Published in Curr Psychiatry Rep on October 01, 2012
Are treatment effects of neurofeedback training in children with ADHD related to the successful regulation of brain activity? A review on the learning of regulation of brain activity and a contribution to the discussion on specificity. Front Hum Neurosci (2015) 0.93
Slow cortical potential and theta/beta neurofeedback training in adults: effects on attentional processes and motor system excitability. Front Hum Neurosci (2014) 0.85
Slow cortical potential neurofeedback and self-management training in outpatient care for children with ADHD: study protocol and first preliminary results of a randomized controlled trial. Front Hum Neurosci (2014) 0.82
Neurofeedback as a treatment for major depressive disorder--a pilot study. PLoS One (2014) 0.81
Self-reported efficacy of neurofeedback treatment in a clinical randomized controlled study of ADHD children and adolescents. Neuropsychiatr Dis Treat (2014) 0.77
Neurofeedback Therapy for Enhancing Visual Attention: State-of-the-Art and Challenges. Front Neurosci (2016) 0.76
The Effects of Fifa 2015 Computer Games on Changes in Cognitive, Hormonal and Brain Waves Functions of Young Men Volunteers. Basic Clin Neurosci (2015) 0.75
Neurofeedback learning modifies the incidence rate of alpha spindles, but not their duration and amplitude. Sci Rep (2017) 0.75
Risperidone in children with autism and serious behavioral problems. N Engl J Med (2002) 9.35
The MTA at 8 years: prospective follow-up of children treated for combined-type ADHD in a multisite study. J Am Acad Child Adolesc Psychiatry (2009) 6.71
Geographic variation in the prevalence of attention-deficit/hyperactivity disorder: the sunny perspective. Biol Psychiatry (2013) 3.47
3-year follow-up of the NIMH MTA study. J Am Acad Child Adolesc Psychiatry (2007) 3.33
Risperidone for the core symptom domains of autism: results from the study by the autism network of the research units on pediatric psychopharmacology. Am J Psychiatry (2005) 2.94
Medication adherence in the MTA: saliva methylphenidate samples versus parent report and mediating effect of concomitant behavioral treatment. J Am Acad Child Adolesc Psychiatry (2009) 2.13
Effects of stimulant medication on growth rates across 3 years in the MTA follow-up. J Am Acad Child Adolesc Psychiatry (2007) 2.03
What aspects of peer relationships are impaired in children with attention-deficit/hyperactivity disorder? J Consult Clin Psychol (2005) 2.03
Which treatment for whom for ADHD? Moderators of treatment response in the MTA. J Consult Clin Psychol (2003) 2.02
Parent-rated anxiety symptoms in children with pervasive developmental disorders: frequency and association with core autism symptoms and cognitive functioning. J Abnorm Child Psychol (2007) 1.98
Delinquent behavior and emerging substance use in the MTA at 36 months: prevalence, course, and treatment effects. J Am Acad Child Adolesc Psychiatry (2007) 1.98
Risperidone and adaptive behavior in children with autism. J Am Acad Child Adolesc Psychiatry (2006) 1.71
A randomized, double-blind, placebo-controlled, parallel-group study of methylphenidate transdermal system in pediatric patients with attention-deficit/hyperactivity disorder. J Clin Psychiatry (2008) 1.70
A systematic review and analysis of long-term outcomes in attention deficit hyperactivity disorder: effects of treatment and non-treatment. BMC Med (2012) 1.67
Characteristics of children with elevated symptoms of mania: the Longitudinal Assessment of Manic Symptoms (LAMS) study. J Clin Psychiatry (2010) 1.67
Validity of the autism diagnostic interview-revised. Am J Ment Retard (2006) 1.66
The services for children and adolescents-parent interview: development and performance characteristics. J Am Acad Child Adolesc Psychiatry (2004) 1.64
Children's Yale-Brown Obsessive Compulsive Scale modified for pervasive developmental disorders. J Am Acad Child Adolesc Psychiatry (2006) 1.61
Medication and parent training in children with pervasive developmental disorders and serious behavior problems: results from a randomized clinical trial. J Am Acad Child Adolesc Psychiatry (2009) 1.55
Secondary evaluations of MTA 36-month outcomes: propensity score and growth mixture model analyses. J Am Acad Child Adolesc Psychiatry (2007) 1.48
Longitudinal Assessment of Manic Symptoms (LAMS) study: background, design, and initial screening results. J Clin Psychiatry (2010) 1.47
Gastrointestinal symptoms in a sample of children with pervasive developmental disorders. J Autism Dev Disord (2008) 1.46
Self-perceptions of competence in children with ADHD and comparison children. J Consult Clin Psychol (2004) 1.43
Peer-assessed outcomes in the multimodal treatment study of children with attention deficit hyperactivity disorder. J Clin Child Adolesc Psychol (2005) 1.41
Neurochemical correlates of autistic disorder: a review of the literature. Res Dev Disabil (2005) 1.38
Assessing medication effects in the MTA study using neuropsychological outcomes. J Child Psychol Psychiatry (2006) 1.34
Parent-reported homework problems in the MTA study: evidence for sustained improvement with behavioral treatment. J Clin Child Adolesc Psychol (2010) 1.31
Reliability of the services for children and adolescents-parent interview. J Am Acad Child Adolesc Psychiatry (2004) 1.31
Assessing Homework Problems in Children with ADHD: Validation of a Parent-Report Measure and Evaluation of Homework Performance Patterns. School Ment Health (2010) 1.27
Evidence, interpretation, and qualification from multiple reports of long-term outcomes in the Multimodal Treatment study of Children With ADHD (MTA): part I: executive summary. J Atten Disord (2008) 1.27
Cost-effectiveness of ADHD treatments: findings from the multimodal treatment study of children with ADHD. Am J Psychiatry (2005) 1.26
Acute and long-term safety and tolerability of risperidone in children with autism. J Child Adolesc Psychopharmacol (2005) 1.24
The transition to middle school is associated with changes in the developmental trajectory of ADHD symptomatology in young adolescents with ADHD. J Clin Child Adolesc Psychol (2008) 1.24
Examining the proposed disruptive mood dysregulation disorder diagnosis in children in the Longitudinal Assessment of Manic Symptoms study. J Clin Psychiatry (2012) 1.23
Socioeconomic status as a moderator of ADHD treatment outcomes. J Am Acad Child Adolesc Psychiatry (2002) 1.23
Methylphenidate treatment in children with borderline IQ and mental retardation: analysis of three aggregated studies. J Child Adolesc Psychopharmacol (2003) 1.23
Patterns and predictors of adolescent academic achievement and performance in a sample of children with attention-deficit/hyperactivity disorder. J Clin Child Adolesc Psychol (2011) 1.20
Effects of short- and long-term risperidone treatment on prolactin levels in children with autism. Biol Psychiatry (2006) 1.18
Evidence, interpretation, and qualification from multiple reports of long-term outcomes in the Multimodal Treatment Study of children with ADHD (MTA): Part II: supporting details. J Atten Disord (2008) 1.18
Blood pressure and heart rate over 10 years in the multimodal treatment study of children with ADHD. Am J Psychiatry (2012) 1.18
Atomoxetine alone or combined with fluoxetine for treating ADHD with comorbid depressive or anxiety symptoms. J Am Acad Child Adolesc Psychiatry (2005) 1.17
Weight and leptin changes among risperidone-treated youths with autism: 6-month prospective data. Am J Psychiatry (2004) 1.16
Response to methylphenidate in children with attention deficit hyperactivity disorder and manic symptoms in the multimodal treatment study of children with attention deficit hyperactivity disorder titration trial. J Child Adolesc Psychopharmacol (2003) 1.15
Peer rejection and friendships in children with Attention-Deficit/Hyperactivity Disorder: contributions to long-term outcomes. J Abnorm Child Psychol (2012) 1.13
EFA supplementation in children with inattention, hyperactivity, and other disruptive behaviors. Lipids (2003) 1.12
Time-dependent changes in positively biased self-perceptions of children with attention-deficit/hyperactivity disorder: a developmental psychopathology perspective. Dev Psychopathol (2010) 1.08
The treatment of severe child aggression (TOSCA) study: Design challenges. Child Adolesc Psychiatry Ment Health (2011) 1.05
Effects of risperidone and parent training on adaptive functioning in children with pervasive developmental disorders and serious behavioral problems. J Am Acad Child Adolesc Psychiatry (2011) 1.05
A review of complementary and alternative treatments for autism spectrum disorders. Autism Res Treat (2012) 1.04
A review of neurofeedback treatment for pediatric ADHD. J Atten Disord (2011) 1.03
Feasibility of a nutritional supplement as treatment for pediatric bipolar spectrum disorders. J Altern Complement Med (2012) 1.03
Artificial food colors and attention-deficit/hyperactivity symptoms: conclusions to dye for. Neurotherapeutics (2012) 1.01
Developmental processes in peer problems of children with attention-deficit/hyperactivity disorder in the Multimodal Treatment Study of Children With ADHD: developmental cascades and vicious cycles. Dev Psychopathol (2010) 1.00
Positive effects of methylphenidate on inattention and hyperactivity in pervasive developmental disorders: an analysis of secondary measures. Biol Psychiatry (2007) 1.00
Dietary sensitivities and ADHD symptoms: thirty-five years of research. Clin Pediatr (Phila) (2010) 0.99
The role of children's ethnicity in the relationship between teacher ratings of attention-deficit/hyperactivity disorder and observed classroom behavior. J Consult Clin Psychol (2005) 0.99
Examining predictors of reaction times in children with ADHD and normal controls. J Int Neuropsychol Soc (2009) 0.98
EEG neurofeedback for ADHD: double-blind sham-controlled randomized pilot feasibility trial. J Atten Disord (2012) 0.97
Treatment-related changes in objectively measured parenting behaviors in the multimodal treatment study of children with attention-deficit/hyperactivity disorder. J Consult Clin Psychol (2006) 0.96
A clinical review of outcomes of the multimodal treatment study of children with attention-deficit/hyperactivity disorder (MTA). Curr Psychiatry Rep (2008) 0.96
Psychopharmacological and other treatments in preschool children with attention-deficit/hyperactivity disorder: current evidence and practice. J Child Adolesc Psychopharmacol (2008) 0.96
Treatment for ADHD: is more complex treatment cost-effective for more complex cases? Health Serv Res (2007) 0.96
Trial design challenges when combining medication and parent training in children with pervasive developmental disorders. J Autism Dev Disord (2008) 0.96
Parental Agreement on ADHD Symptom-Specific and Broadband Externalizing Ratings of Child Behavior. J Emot Behav Disord (2010) 0.95
Serum ferritin and amphetamine response in youth with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol (2010) 0.94
Examination of aggression and self-injury in children with autism spectrum disorders and serious behavioral problems. Child Adolesc Psychiatr Clin N Am (2014) 0.94
A prospective open trial of guanfacine in children with pervasive developmental disorders. J Child Adolesc Psychopharmacol (2006) 0.94
Bipolar and ADHD Comorbidity: Both Artifact and Outgrowth of Shared Mechanisms. Clin Psychol (New York) (2010) 0.94
Treatment of inattention, overactivity, and impulsiveness in autism spectrum disorders. Child Adolesc Psychiatr Clin N Am (2008) 0.94
Positive effects of methylphenidate on social communication and self-regulation in children with pervasive developmental disorders and hyperactivity. J Autism Dev Disord (2008) 0.94
Effects of once-daily oral and transdermal methylphenidate on sleep behavior of children with ADHD. J Atten Disord (2008) 0.93
Multinutrient supplement as treatment: literature review and case report of a 12-year-old boy with bipolar disorder. J Child Adolesc Psychopharmacol (2009) 0.92
Research knowledge among parents of children participating in a randomized clinical trial. J Am Acad Child Adolesc Psychiatry (2005) 0.89
High concordance of parent and teacher attention-deficit/hyperactivity disorder ratings in medicated and unmedicated children with autism spectrum disorders. J Child Adolesc Psychopharmacol (2012) 0.89
Relation between outcomes on a continuous performance test and ADHD symptoms over time. J Abnorm Child Psychol (2011) 0.88
Does switching from oral extended-release methylphenidate to the methylphenidate transdermal system affect health-related quality-of-life and medication satisfaction for children with attention-deficit/hyperactivity disorder? Child Adolesc Psychiatry Ment Health (2009) 0.88
Parent satisfaction in a multi-site acute trial of risperidone in children with autism: a social validity study. Psychopharmacology (Berl) (2006) 0.88
What differentiates children visiting outpatient mental health services with bipolar spectrum disorder from children with other psychiatric diagnoses? Bipolar Disord (2012) 0.86
Developmental disabilities modification of the Children's Global Assessment Scale. Biol Psychiatry (2007) 0.86
Maternal depressive symptomatology and parenting behavior: exploration of possible mediators. J Abnorm Child Psychol (2007) 0.86
Empirical evaluation of the generalizability of the sample from the multimodal treatment study for ADHD. Adm Policy Ment Health (2006) 0.86
Cognitive effects of risperidone in children with autism and irritable behavior. J Child Adolesc Psychopharmacol (2008) 0.86
Phenomenology of bipolar disorder not otherwise specified in youth: a comparison of clinical characteristics across the spectrum of manic symptoms. Bipolar Disord (2013) 0.86
Impact of ADHD and cannabis use on executive functioning in young adults. Drug Alcohol Depend (2013) 0.86
Clinical characteristics of children receiving antipsychotic medication. J Child Adolesc Psychopharmacol (2011) 0.86
Parents' perceptions of benefit of children's mental health treatment and continued use of services. Psychiatr Serv (2012) 0.85
Mental health service use by children with serious emotional and behavioral disturbance: results from the LAMS study. Psychiatr Serv (2011) 0.84
Ethical issues in child psychopharmacology research and practice: emphasis on preschoolers. Psychopharmacology (Berl) (2007) 0.83
Developmental progression to early adult binge drinking and marijuana use from worsening versus stable trajectories of adolescent attention deficit/hyperactivity disorder and delinquency. Addiction (2015) 0.83
Mood-related sleep problems in children and adolescents. Child Adolesc Psychiatr Clin N Am (2009) 0.83
Participant satisfaction in a study of stimulant, parent training, and risperidone in children with severe physical aggression. J Child Adolesc Psychopharmacol (2015) 0.83
Standardised Observation Analogue Procedure (SOAP) for assessing parent and child behaviours in clinical trials. J Intellect Dev Disabil (2009) 0.83
Possible influence of variant of the P-glycoprotein gene (MDR1/ABCB1) on clinical response to guanfacine in children with pervasive developmental disorders and hyperactivity. J Child Adolesc Psychopharmacol (2010) 0.83
Effects of extended release methylphenidate treatment on ratings of attention-deficit/hyperactivity disorder (ADHD) and associated behavior in children with autism spectrum disorders and ADHD symptoms. J Child Adolesc Psychopharmacol (2013) 0.83
Use of outpatient mental health services among children of different ages: are younger children more seriously ill? Psychiatr Serv (2014) 0.82
Bulimia nervosa symptoms in the multimodal treatment study of children with ADHD. Int J Eat Disord (2010) 0.82
Emotional face processing in pediatric bipolar disorder: evidence for functional impairments in the fusiform gyrus. J Am Acad Child Adolesc Psychiatry (2013) 0.82